Table 5. Association between circulating ANGPTL4 levels and laboratory tests relevant to impaired glycometabolism, hepatic impairment or inflammation (n = 800).

A generalized linear model was used. To evaluate HbA_1C or glucose, each covariate was adjusted by all variables listed in Table 3, minus the impaired glyometabolism category. To evaluate AST, ALT, or GGT, each covariate was adjusted by all variables listed in Table 3, minus the hepatic impairment category. To evaluate hs-CRP, each covariate was adjusted by all variables listed in Table 3, minus inflammation. β, regression coefficient; 95% CI, 95% confidence interval; HbA_1C, hemoglobin A_1C; AST, aspartate transaminase; ALT, alanine transaminase; GGT, Gamma-glutamyltransferase; and hs-CRP, high sensitivity C reactive protein.

	log(ANGPTL4)
	β	95%CI	P
Impaired glycometabolism
log(HbA1c)	0.463	(0.130, 0.797)	0.007
log(Glucose)	0.271	(0.044, 0.498)	0.019
Hepatic impairment
log(AST)	0.236	(0.129, 0.343)	<.001
log(ALT)	0.077	(0.013 0.141)	0.018
log(GGT)	0.065	(0.018, 0.113)	0.007
Inflammation
log(hs-CRP)	-0.021	(-0.045, -0.004)	0.094